136 views | 9 years ago
Dr. Robert Anderson, Director of the Southern California Center for Reproductive Medicine and Medical Director for the Southern California Institute for Reproductive Sciences, discusses the high percentage...
134 views | 1 decade ago
The Belnap family discuss their diagnostic odyssey
125 views | 1 decade ago
Part 4 - Next-generation sequencing technology advancements and informatics understanding have brought us to the point where you can build a "portable" genome. Illumina product experts discuss how next-generation...
123 views | 5 years ago
Watch this video to hear about TruSight™ Oncology 500 (TSO500), our solution to enable comprehensive genomic profiling. Get pan-cancer coverage targeting 523 genes from this comprehensive next-generation...
113 views | 5 years ago
Hundreds of thousands of variants have been discovered. We know these variants affect cellular processes and play a part in complex diseases, but we don’t know how. Variant to function (V2F) research...
112 views | 5 years ago
Should we do ever larger genome-wide association studies? Will large scale population sequencing studies for dementia be productive in going after rare variants? Should we be investing more effort in...
108 views | 1 decade ago
Michael Quail, The Wellcome Trust Institute Dr. Quail attends AGBT to evaluate new technologies and look for new platforms and reagents to expand his lab's R&D applications.
102 views | 7 years ago
In this webinar, Dr. Jamuar discusses the optimal technique for the detection of somatic mosaicism. He evaluates the limitations of Sanger sequencing and highlights the advantages of targeted next-generation...